Archive for May 2017

The Homeopathic Pharmacopoeia of the United States

By Mark Land, AAHP president June 1, 2017 The Homeopathic Pharmacopoeia of the United States (HPUS) is the legal basis for marketing homeopathic drug products in the United States and many other countries around the world. The HPUS is officially recognized in the United States Federal Food Drug and Cosmetic readm more…

Read More

2017 Updates in the Homeopathic Pharmacopeia

By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Before proceeding to review the major areas of updates in the HPUS, two specific items are of timely interest: The Guidelines for Manufacturing Homeopathic Medicines became official on March 31, 2017. The older General Pharmacy section and the Classes readm more…

Read More

What is the HPUS and Who Creates It?

By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Various pharmacopoeias containing homeopathic drugs have been published continually since the 1840s. The Homeopathic Pharmacopoeia of the United States (HPUS) has been in continuous publication for 120 years — since 1897. The HPUS was officially recognized under the U.S. readm more…

Read More

Delivering Key Messages

By Alissa Gould, public relations manager, Boiron USA June 1, 2017 Building on April and May 2017 articles on preparing for important communications and developing key messages, this article will focus on delivering those messages. Now that you have a mental road map of where you want to drive the readm more…

Read More

Developing Key Messages

By Alissa Gould, public relations manager, Boiron USA May 1, 2017 Last month (April 2017), I shared an article on being prepared and asking the right questions for media interviews or other situations. This article builds on reviewing communications basics by discussing message development. Whether you are meeting a retailer readm more…

Read More

Homeopathic Manufacturers Explore Next-Generation Quality Control

MILWAUKIE, Ore., May 4, 2017 — Member companies of the American Association of Homeopathic Pharmacists (AAHP) gathered to learn about promising new technologies recently used by the U.S. Food and Drug Administration (FDA) to analyze homeopathic products. Developments in this area could lead to industry-wide manufacturing advancements as well as readm more…

Read More